Top compounds associated with response to DLST


Feature Type Standardized
Nominal ANOVA
mRNA CCT007093 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA BRD-K42260513 CTRPv2 pan-cancer AAC -0.019 0.7
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.011 0.7
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.011 0.7
mRNA RITA CTRPv2 pan-cancer AAC 0.012 0.7
mRNA QL-VIII-58 GDSC1000 pan-cancer AAC -0.015 0.7
mRNA hyperforin CTRPv2 pan-cancer AAC -0.013 0.7
mRNA temsirolimus GDSC1000 pan-cancer AAC -0.011 0.7
mRNA ML239 CTRPv2 pan-cancer AAC -0.012 0.7
Download CSV